REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · IEX Real-Time Price · USD
10.75
-0.32 (-2.89%)
At close: Jul 2, 2024, 4:00 PM
10.78
+0.03 (0.28%)
After-hours: Jul 2, 2024, 5:06 PM EDT
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $529.50 million as of July 2, 2024. Its market cap has decreased by -35.54% in one year.
Market Cap
529.50M
Enterprise Value
276.02M
1-Year Change
-35.54%
Ranking
Category
Stock Price
$10.75
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $529.50M, a decrease of -29.33%. That is a compound annual growth rate of -3.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 545.30M | -30.95% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 580.35M |
| Replimune Group | 574.85M |
| IRadimed | 550.13M |
| National Research | 546.79M |
| Paragon 28 | 545.82M |
| iTeos Therapeutics | 542.20M |
| Pharming Group | 542.12M |
| Contineum Therapeutics | 540.19M |